K Csóka
Impact in
-
- Cancer Treatment and Pharmacology
- Drug Transport and Resistance Mechanisms
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research
-
- Chronic Lymphocytic Leukemia Research
Papers in
- Oncology 10
- Cancer Treatment and Pharmacology 4
- Drug Transport and Resistance Mechanisms 2
- Colorectal Cancer Treatments and Studies 2
-
- Cancer therapeutics and mechanisms 5
- Retinoids in leukemia and cellular processes 2
- Co-authors
- Peter Nygren (14 shared papers)Rolf Larsson (11 shared papers)H Fridborg (8 shared papers)Sumeer Dhar (5 shared papers)Bengt Tholander (5 shared papers)Jörgen Kristensen (6 shared papers)Jan Liliemark (2 shared papers)Kenneth Nilsson (4 shared papers)
In The Last Decade
K Csóka
19 papers receiving 490 citations
Peers
Comparison fields: 5 of 75
- Oncology 178
- Genetics 38
- Molecular Biology 213
- Toxicology 10
- Cancer Research 35
Countries citing papers authored by K Csóka
This map shows the geographic impact of K Csóka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Csóka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Csóka more than expected).
Fields of papers citing papers by K Csóka
This network shows the impact of papers produced by K Csóka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Csóka. The network helps show where K Csóka may publish in the future.
Co-authors
The 25 scholars most cited alongside K Csóka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 71 | |
| 2 | 1996 | 69 | |
| 3 | Evaluation of the cytotoxic activity of gemcitabine in primary cultures of tumor cells from patients with hematologic or solid tumors. | 1995 | 58 |
| 4 | 1994 | 52 | |
| 5 | 1995 | 43 | |
| 6 | 1997 | 39 | |
| 7 | 1996 | 37 | |
| 8 | 1994 | 30 | |
| 9 | 1990 | 23 | |
| 10 | 1994 | 17 | |
| 11 | 2000 | 14 | |
| 12 | 1990 | 11 | |
| 13 | In vitro evaluation of new anticancer drugs, exemplified by vinorelbine, using the fluorometric microculture cytotoxicity assay on human tumor cell lines and patient biopsy cells. | 1996 | 11 |
| 14 | 1995 | 9 | |
| 15 | 1999 | 9 | |
| 16 | 1992 | 8 | |
| 17 | 2000 | 6 | |
| 18 | Cytotoxic action of cyclosporins on human tumor cell lines is not dependent on immunosuppressive activity. | 1992 | 6 |
| 19 | The Fluorometric Microculture Cytotoxicity Assay (FMCA) in assessment of the clinical activity of cytotoxic drugs : with special reference to ovarian carcinoma | 1997 | 2 |
About K Csóka
K Csóka is a scholar working on Oncology, Molecular Biology, Genetics, Computational Theory and Mathematics and Pharmacology, having authored 19 papers that have together received 515 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (5 papers), Cancer Treatment and Pharmacology (4 papers), Microtubule and mitosis dynamics (2 papers), Retinoids in leukemia and cellular processes (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Computational Drug Discovery Methods (2 papers), Colorectal Cancer Treatments and Studies (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). The work is most often cited by research in Oncology (178 citations), Genetics (38 citations), Molecular Biology (213 citations), Toxicology (10 citations) and Cancer Research (35 citations). K Csóka has collaborated with scholars based in Sweden, Germany and Norway. Frequent co-authors include Peter Nygren, Rolf Larsson, H Fridborg, Sumeer Dhar, Bengt Tholander, Jörgen Kristensen, Jan Liliemark, Kenneth Nilsson, Jonas Bergh and Bertil Jönsson. Their work appears in journals such as British Journal of Cancer, European Journal of Cancer, International Journal of Cancer, Gynecologic Oncology and Prostaglandins Leukotrienes and Essential Fatty Acids.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.